Entropy Technologies LP Takes 1.41 Million Position in Bio-Rad Laboratories, Inc.
| CRIMX Fund | USD 26.71 0.15 0.56% |
Slightly above 62% of Crm Mid's investor base is looking to short. The analysis of overall sentiment of trading Crm Mid Cap mutual fund suggests that many investors are alarmed at this time. Crm Mid's investing sentiment can be driven by a variety of factors including economic data, Crm Mid's earnings reports, geopolitical events, and overall market trends.
Crm |
Entropy Technologies LP purchased a new stake in shares of Bio-Rad Laboratories, Inc. during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 4,200 shares of the medical research companys stock, valued at approximately 1,405,000. A number of other institutional investors have
Read at thelincolnianonline.com
 |
Crm Mid Fundamental Analysis
We analyze Crm Mid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Crm Mid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Crm Mid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Crm Mid is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Crm Mid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Crm Mid mutual fund to make a market-neutral strategy. Peer analysis of Crm Mid could also be used in its relative valuation, which is a method of valuing Crm Mid by comparing valuation metrics with similar companies.
Peers
Crm Mid Related Equities
| VIEIX | Vanguard Extended | 1.25 | ||||
| FSMAX | Fidelity Extended | 1.25 | ||||
| VMCIX | Vanguard Mid-cap | 0.06 | ||||
| VMCPX | Vanguard Mid-cap | 0.06 | ||||
| VIMAX | Vanguard Mid | 0.06 | ||||
| VIMSX | Vanguard Mid | 0.05 | ||||
| VEXAX | Vanguard Extended | 0.62 | ||||
| VEMPX | Vanguard Extended | 0.62 | ||||
| VEXMX | Vanguard Extended | 0.62 | ||||
| VSEMX | Vanguard Extended | 0.63 |
Other Information on Investing in Crm Mutual Fund
Crm Mid financial ratios help investors to determine whether Crm Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crm with respect to the benefits of owning Crm Mid security.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |